Loading transcript...
Click for full transcript
Chapters & Sections (249)
▼
0:32
Meeting Dave Chappelle and Appreciation for Maps' Work
1:02
Early Life Choices and Focus on Psychedelics
1:33
Draft Resistance and Nonviolent Resistance
3:37
Draft Resistance and Jimmy Carter's Pardon
4:42
Vietnam War Criticism and False Flag Operations
5:44
Daniel Ellsberg's Role in Pentagon Papers Release
6:14
Reflection on Courage and Civil Disobedience
7:16
Building Support for Psychedelics among Veterans and Conservatives
7:47
Changing Perceptions of Psychedelics through Positive Experiences
8:18
Personal Stories of Transformation and Service
9:20
Finding Common Ground with Unlikely Allies
10:54
Rebecca Mercer's Donation and Its Impact
11:26
Meeting an Unlikely Person at the Seder
11:56
Discussion on MDMA Therapy and Grief
12:28
Ethical Dilemma and the Importance of Common Ground
13:29
The Power of Psychedelics in Bridging Political Divides
13:59
Personal Experiences and Overcoming Ideological Dogma
15:04
Challenging drug-related stereotypes and personal experiences with psychedelics
16:08
The profound impact of DMT experiences on one's perspective and understanding of life
17:12
The role of psychedelics in abandoning preconceived notions and connecting with a deeper sense of self
18:46
The Unbelievable Nature of Psychedelic Experiences
19:17
Realization and Patterns in Life
19:47
The Impact of Psychedelic Research on Success
20:18
Falling into Patterns and the Importance of Breakthroughs
20:49
The First 5-Meo Experience
22:23
Ian Experience and Addiction Treatment
22:55
Governor Perry's Interest in Ian and Military Veterans
23:57
Personal Connection to Aubrey Marcus and Michael Marcus' Research
24:29
Stan Grof's Work on Holotropic Breathwork and Psychedelics
25:01
Michael Marcus' Experience with Ibigan and Regaining Confidence
26:03
Securing Funding for a Study in Jordan
27:04
Expanding Research to New Locations and Partnerships
27:36
The Example of Iain and Its Potential Applications
33:21
Founding the Non-Profit and Preparing for DEA Action
33:53
Leo's Offer to Help with Personal Growth
34:25
First LSD Experience and Comparison to Ibigan
34:59
Emotional Turmoil and Ego Dissolution during LSD Experience
37:06
The Cycle of Self-Criticism and Self-Hatred
38:06
The Realization of the Need to Keep Self-Criticism and Sever the Connection with Self-Hatred
38:37
The Story of Not Earning a Breakthrough and the Consequences of Negative Self-Talk
40:11
Initial Experience with Psychedelics and Self-Discovery
41:45
Painful Experience with Self-Hatred and Psychedelics
42:18
Discussion of Iain and its Potential for Treatment
43:51
Potential Changes to MDMA Scheduling
44:23
Reform and the Post-Prohibition World
45:24
The Opiate Epidemic and MDMA Availability
45:54
Criminalization of Psychedelics and the Drug War
47:27
Sharing Personal Experience with Prostate Cancer and Surgery
47:57
Discussion of Wearing Adult Diapers after Surgery
48:29
Humorous Take on Wearing Adult Diapers at Burning Man
49:30
Reflections on the Future of Drug Policy and Stigma
51:04
Focusing on Relationships, Not Substances
51:36
Reducing Supply and Threats
52:08
Dangerous Drugs and Legalization
53:11
Treatment on Demand and Lost Opportunities
54:44
The MTV Show and Misleading Brain Scan Results
55:15
Oprah's Show and the Attempt to Scare a Young Woman
56:17
The Fake Brain Scan Results and the Consequences
57:51
Oprah's Initial Story on MDMA and its Therapeutic Use
58:24
The Woman's Story and the Article in O Magazine
58:55
Critique of Sensationalist Media Coverage of Psychedelics
59:57
Public Education on Psychedelics and the Upcoming Conference
1:01:31
Potential Applications of MDMA for Prisoners and Victims
1:02:01
The Burden of Trauma and the Goal of Net Zero Trauma
1:02:32
Epigenetics and Intergenerational Trauma
1:03:35
The Future of Mental Health and Spirituality
1:04:06
Psychedelic Science Conference and Opportunities for Involvement
1:05:10
Denver's Decriminalization of Mushrooms and Marijuana
1:06:10
Psychedelic Science Conference and Education
1:07:43
For-Profit Psychedelic Companies and Research
1:08:47
Patent Strategies and Public Domain Concerns
1:09:17
Pharmaceutical Company Involvement and Patenting
1:10:00
Non-Profit Funding and Royalty Share
1:11:50
Non-Profit Structure and Public Benefit Prioritization
1:12:22
Critique of Capitalism and Introduction to Public Benefit Corporations
1:13:25
Public Benefit Pharmaceutical Company and Capital Raising
1:14:27
Successful Phase 3 Study Results and Statistical Significance
1:15:01
Treatment Efficacy and Response Rates in PTSD Patients
1:17:05
Addressing Previous Concerns about MDMA and Dopamine
1:18:42
Mitigation Techniques for MDMA Use
1:19:12
MDMA Safety and Observation
1:19:43
5hdp and Therapy
1:20:15
Serotonergic Neurotoxicity and Time Bomb Theories
1:20:46
MDMA Safety in Primates and Parkinson's Research
1:21:17
Questioning the Science and Neurotoxicity in Crowds
1:22:50
Research Triangle Institute's Mistake and Blame Game
1:23:21
Consequences of the Mix-Up and Retraction of Data
1:23:52
Peter Jennings' Documentary and the Problem with Methamphetamine
1:24:23
Speculation on Sabotage and Irresponsibility of Researchers
1:24:54
Personal Experience with Spinal Tap and Neurotoxicity Research
1:26:29
Personal Experience with MDMA and Research Motivation
1:27:00
Critique of DeSantis' Actions and New College's Honors Program
1:27:32
George Soros' Potential Involvement in New College and Public Education
1:28:35
MDMA Research Findings and Critique of Prior Studies
1:29:05
The Good Friday Experiment and Long-Term Follow-Up Studies
1:29:36
Bill W's Initial LSD Experience and its Impact on Sobriety
1:30:07
Discussion of Belladon and its Properties
1:30:40
The Use of Scopolamine in Voodoo Cults and its Connection to Sobriety
1:31:10
Bill W's Second LSD Experience and its Connection to Sobriety
1:31:42
The Potential of LSD in AA and its Controversy
1:32:45
The Good Friday Experiment and its Findings on Psychedelics
1:33:16
Howard Thurman's Connection to Gandhi and Martin Luther King
1:33:49
Non-Violent Resistance in the American Civil Rights Movement
1:34:20
The Connection Between Mystical Experience and Political Action
1:34:53
The Good Friday Experiment and its Significance
1:35:58
Long-Term Follow-Up of the Good Friday Experiment and its Impact
1:36:59
The Fruits Test and Its Impact on Life
1:37:30
Trying to Find the Study Participants
1:38:01
Finding the List of Students and Identifying Participants
1:38:32
Theories of Change and the Results of the Study
1:40:08
Story of a Man on the Cross and His Arrest
1:40:41
Exaggeration of Risks and Suppression of Benefits
1:41:11
Discussion of Marijuana's Dangers and Risks
1:41:43
Concerns about Vulnerability to Mental Illness
1:43:16
Potential Backlash and FDA Approval
1:43:47
Control of Mind and Psychedelics
1:44:19
Jamie's Experience with Edibles
1:44:50
Personal Anecdote about THC and CBD
1:45:52
Negative Experience with Edibles
1:46:54
The Power of Propaganda in Shaping Public Opinion
1:47:25
The Demonization of Cannabis and the Role of Harry Anslinger
1:47:56
The Impact of Propaganda on Generations and the Importance of Education
1:48:28
The Current State of Conversations and the Importance of Honesty
1:50:01
Discussing Drug Risks with Children
1:50:32
Fentanyl Contamination in Illicit Drugs
1:51:34
The Ineffectiveness of Prohibition and the Need for Legalization
1:52:04
Historical Context of Prohibition and the Media's Role in Shaping Public Opinion
1:53:05
The Need for Real Journalists and the Prison Experiment
1:53:37
The Conquered Prison Experiment and its Significance
1:54:38
Follow-up Study on the Conquered Prison Experiment
1:56:12
The Experiment's Failure and the Discovery of a Trick
1:57:16
Comparing Results to Historical Data
1:57:47
Exposing Scientific Fraud and Misrepresentation
1:59:20
Fraudulent Recidivism Rates and the Difficulty of Changing Behavior
1:59:50
The Challenge of Stopping Crime after Incarceration
2:00:21
The Importance of Support and Aftercare
2:00:51
The Need for a Proper Experiment and Integration
2:02:55
Using Psychedelics for Rehabilitation
2:03:26
Comparing Rehab Approaches
2:04:28
Personal Experience with Cities at Night
2:05:01
Government Support for Psychedelic Research
2:06:32
The Uniqueness of the 'Brain on Drugs' Moment
2:07:03
The Influence of Michael Pollin's Work
2:08:05
Challenges and Risks in the Current Moment
2:09:11
The Dangers of Mixing Sacred Substances with Commerce
2:09:41
Initial Concerns about Going Public and Commercialization
2:11:49
Potential Benefits of Going Public, Including Accelerating Legalization
2:12:51
Options for Funding and Sustainability after FDA Approval
2:13:22
Potential Upsides of Going Public and Royalty Payments
2:13:53
Net Zero Trauma by 2070 and Global Perspective
2:14:24
Humanity's Survival and the Importance of Public Benefit
2:14:55
Balancing Public Benefit with Investor Returns
2:15:25
Considering Alternative Funding Options and Risk Management
2:17:33
Assumptions about MDMA and PTSD Treatment
2:18:03
Personal Experience with MDMA and PTSD
2:18:35
Misconceptions about FDA Regulation and Patents
2:19:38
Discovery of Patent Lawyer and Cluster Headaches Treatment
2:20:40
Patient's Experience with LSD and MDMA
2:22:15
Harvard's Restrictions on Psychedelic Research
2:22:45
Bromo LSD and its Effectiveness
2:23:46
Data Exclusivity and its Incentives for Off-Patent Drugs
2:24:47
FDA Restrictions and Data Exclusivity Extension
2:25:20
Impact of Data Exclusivity on Business and Research
2:26:52
Future Plans and Sustainability
2:27:23
Data Exclusivity and Automatic Return of Money
2:27:53
Methodological Problem with Double Blind Studies
2:28:24
Special Protocol Assessment and FDA Negotiations
2:29:56
Dissertation and Low Dose MDMA Therapy
2:30:59
Low Doses of MDMA and Turbulence
2:31:30
Surprising Benefits of 75mg Dose Group
2:32:01
Blinding and Placebo Effect
2:32:32
Reducing Bias in Experimentation
2:33:35
Side Effects and Risk of Therapy
2:34:06
Therapy Approval and FDA Boundaries
2:34:39
Confidence in Data Validity and Safety Record
2:35:11
Design and Prior Agreement with FDA
2:35:42
Bipartisan Support and Political Neutrality
2:36:15
Regulation and Controls Following Approval
2:37:19
Sil cybin and FDA Approval for Depression Treatment
2:38:55
Philanthropy and Capital Access for Psychedelic Research
2:39:57
Personal Anecdote about Bar Mitzvah and Teaching Kids
2:40:30
Sharing marijuana with children and setting boundaries
2:41:02
Approach to drug education for teenagers
2:41:35
Dangers of drug use and importance of education
2:42:38
Benefits of going public for a benefit corporation
2:44:12
Potential for Non-Profit Pharmaceutical Industry Model
2:44:45
Crossroads in Psychedelic Research and Business
2:45:16
Pricing Theories and Public Benefit Corporation
2:45:46
Challenges in Patient Assistance Programs and Therapy Costs
2:47:21
Potential Risks and Prevalence of Illegal Activity
2:48:23
Addressing Price and Profit in Psychedelic Treatment
2h 58m⏭ 2
2h 21m⏭ 3
2h 53m⏭ 2
3h 1m⏭ 2
2h 54m⏭ 2
3h 35m
3h 7m⏭ 2
2h 39m⏭ 2
2h 58m⏭ 2
2h 34m⏭ 3
2h 19m
2h 49m⏭ 2
1h 6m⏭ 3
1h 42m⏭ 3
1h 18m⏭ 4
1h 6m⏭ 1
38m
2h 37m⏭ 2
2h 0m⏭ 2
1h 14m⏭ 2
1h 9m⏭ 3
1h 17m
1h 1m
1h 14m⏭ 1